Elise Kayson

2.8k citations

22 papers · 1.4k indexed · 1 hit paper · h-index 10

Impact in

Cellular and Molecular Neuroscience top 1%
- Genetic Neurodegenerative Diseases
- Neuroscience and Neuropharmacology Research
Neurology top 1%
- Neurological disorders and treatments
- Parkinson's Disease Mechanisms and Treatments
- Neurology and Historical Studies
- Botulinum Toxin and Related Neurological Disorders

Papers in

Cellular and Molecular Neuroscience 21
- Genetic Neurodegenerative Diseases 21
Neurology 12
- Neurological disorders and treatments 11
- Parkinson's Disease Mechanisms and Treatments 3
- Botulinum Toxin and Related Neurological Disorders 2
- Alcoholism and Thiamine Deficiency 1

Co-authors: Ira Shoulson Jane S. Paulsen David Oakes Martha Nance Mark Guttman Douglas R. Langbehn Michael R. Hayden Elizabeth Aylward
Journals: Neurology (6 papers)Neurotherapeutics (3 papers)Journal of Huntington s Disease (3 papers)CNS Spectrums (2 papers)Movement Disorders (1 paper)
Partner nations: United States Canada Australia

In The Last Decade

Elise Kayson

18 papers receiving 1.4k citations

Hit Papers

align trajectories log scale

Detection of Huntington's disease decades before diagnosis: the Predict-HD study 2007 · 605 citations

Peers

Countries citing papers authored by Elise Kayson

Since Specialization

Citations

This map shows the geographic impact of Elise Kayson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elise Kayson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elise Kayson more than expected).

Fields of papers citing papers by Elise Kayson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elise Kayson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elise Kayson. The network helps show where Elise Kayson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Elise Kayson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Elise Kayson Line = papers co-authored together Elise Kayson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Safety and Efficacy of Deutetrabenazine at High versus Lower Daily Dosages in the ARC-HD Study to Treat Chorea in Huntington Disease CNS Drugs ·Samuel Frank, Sen Fang, Jody Goldstein, Elise Kayson, Blair R. Leavitt, David Oakes, Christine J. O’Neill, Jacquelyn Whaley, Nicholas J. Gross, 邓运奇, Steve Barash, Mark Forrest Gordon, (unknown)	2025	1
2	Sustained Improvements in Chorea Associated with Huntington Disease with Once-Daily Valbenazine: Interim Results from a Long-Term Open-Label Study CNS Spectrums ·Erin Furr Stimming, Daniel O. Claassen, Elise Kayson, Jody Goldstein, Sean C. Hinton, Olga Klepitskaya, F. Bozorgmehr, Grace Liang, Dietrich Haubenberger	2024	1
3	A Wearable Movement Sensor Substudy of KINECT®-HD, a Phase 3 Trial of Valbenazine for the Treatment of Chorea Associated with Huntington’s Disease (P8-3.010) Neurology ·Jamie Adams, Erin Furr Stimming, Daniel O. Claassen, Elise Kayson, Jody Goldstein, Sean C. Hinton, Olga Klepitskaya, Hui Zhang, Grace Liang, 順佐久間, Sean M. Mitchell, Dietrich Haubenberger	2024	0
4	Sustained Improvements with Once-daily Valbenazine in Chorea Associated with Huntington’s Disease: Interim Results from a Long-term Open-label Study (S30.003) Neurology ·Erin Furr Stimming, Daniel O. Claassen, Elise Kayson, Jody Goldstein, Sean C. Hinton, Olga Klepitskaya, F. Bozorgmehr, Grace Liang, Dietrich Haubenberger	2024	1
5	What Huntington’s Disease Patients Say About Their Illness: An Online Direct-to-Participant Pilot Study Journal of Huntington s Disease ·Karen E. Anderson, Aditya Prasetyo, Mr. Titas Rudra, Andrew Feigin, Jody Goldstein, Elise Kayson, H. Udluft, Yaritza Y. Quintal-Vargas, Dinesh K.C., Noelle E. Carlozzi, Samuel Frank, Henry G. Triay, Sandra K. Kostyk, Emily S. Chang, A. Nonnast, 泰博小部, Christopher A. Beck, Ira Shoulson	2024	0
6	Evaluation of the Safety of Deutetrabenazine at Higher Doses to Treat Chorea in Huntington’s Disease (4310) Neurology ·Samuel Frank, Christina Vaughan, David Stamler, David Oakes, Mat D. Davis, Nicholas J. Gross, Mark Forrest Gordon, Juha‐Matti Savola, Morgan Bennett, Shirley Eberly, Elise Kayson, Jacquelyn Whaley, Jody Goldstein, Claudia Testa	2020	0
7	The Prospective Huntington At-Risk Observational Study (PHAROS): The Emotional Well-Being, Safety and Feasibility of Long-Term Research Participation Journal of Huntington s Disease ·Elise Kayson, (unknown), Shirley Eberly, Karen E. Anderson, Karen Marder, Ira Shoulson, David Oakes, Anne B. Young, Kevin Biglan, Steven M. Hersch	2019	1
8	Phenotype–genotype discrepancies in the prospective Huntington at‐risk observational study Annals of Clinical and Translational Neurology ·Ira Shoulson, Shirley Eberly, David Oakes, Elise Kayson, Anne B. Young, (unknown)	2019	2
9	The choice not to undergo genetic testing for Huntington disease: Results from the PHAROS study Clinical Genetics ·Karen E. Anderson, Shirley Eberly, Karen Marder, David Oakes, Elise Kayson, Anne B. Young, Ira Shoulson, (unknown)	2019	11
10	Risk Factors for Suicidal Ideation in People at Risk for Huntington’s Disease Journal of Huntington s Disease ·Karen E. Anderson, (unknown), Shirley Eberly, Mark Groves, Elise Kayson, Karen Marder, Anne B. Young, Ira Shoulson	2016	16
11	Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS Neurology ·Annie Killoran, Kevin Biglan, Joseph Jankovic, Shirley Eberly, Elise Kayson, David Oakes, Anne B. Young, Ira Shoulson	2013	63
12	Fear of health insurance loss among individuals at risk for Huntington disease American Journal of Medical Genetics Part A ·Emily Oster, E. Ray Dorsey, A. Wilder-Smith, Aileen Shinaman, Elise Kayson, David Oakes, Ira Shoulson, Kimberly A. Quaid	2008	23
13	Five Years of Monitoring the Safety and Feasibility of PHAROS (Prospective Huntington At Risk Observational Study) Neurotherapeutics ·Elise Kayson	2008	1
14	Poster 21: Insurance Ownership and Genetic Risk Neurotherapeutics ·Yusuke Iguchi, Juan Roberto González-Cano, Aileen Shinaman, Elise Kayson, David Oakes, Ira Shoulson, Kimberly A. Quaid, E. Ray Dorsey	2008	0
15	Influence of Insurance on the Decision to Pursue Genetic Testing in Individuals at Risk for Huntington’s Disease Neurotherapeutics ·Yusuke Iguchi, E. Ray Dorsey, Juan Roberto González-Cano, Aileen Shinaman, Elise Kayson, David Oakes, Ira Shoulson, Kimberly A. Quaid	2008	2
16	Verbal episodic memory declines prior to diagnosis in Huntington's disease Neuropsychologia ·Andrea C. Solomon, Julie C. Stout, Hans J. Johnson, Douglas R. Langbehn, Elizabeth Aylward, Jason Brandt, Christopher A. Ross, Leigh J. Beglinger, Michael R. Hayden, Karl Kieburtz, Elise Kayson, Hsin-tzu Tai, Karen Duff, Mark Guttman, Martha Nance, David Oakes, Ira Shoulson, Elizabeth Penziner, Jane S. Paulsen	2007	101
17	Detection of Huntington's disease decades before diagnosis: the Predict-HD study Journal of Neurology Neurosurgery & Psychiatry ·Jane S. Paulsen, Douglas R. Langbehn, Julie C. Stout, Elizabeth Aylward, C A Ross, Martha Nance, Mark Guttman, R.V. Jeba Rajasekhar, Marcy E. MacDonald, Leigh J. Beglinger, Karen Duff, Elise Kayson, Kevin Biglan, Ira Shoulson, David Oakes, Michael R. Hayden, (unknown) Hit paper breakdown →	2007	605
18	Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease Brain ·Hans J. Johnson, Julie C. Stout, Andrea C. Solomon, Douglas R. Langbehn, Elizabeth Aylward, Mugdha Gupta, Christopher A. Ross, Martha Nance, Elise Kayson, Hsin-tzu Tai, Michael R. Hayden, Karl Kieburtz, Mark Guttman, David Oakes, Ira Shoulson, Leigh J. Beglinger, Karen Duff, Elizabeth Penziner, Jane S. Paulsen, (unknown)	2007	160
19	Interrater agreement in the assessment of motor manifestations of Huntington's disease Movement Disorders ·Penelope Hogarth, Elise Kayson, Karl Kieburtz, Karen Marder, David Oakes, Diana Rosas, Ira Shoulson, Nancy S. Wexler, Anne B. Young, Hongwei Zhao, (unknown)	2004	54
20	Predictors of nursing home placement in Huntington disease Neurology ·Taku Orita, Teresa Tempkin, Karen Marder, Martha Nance, Richard H. Myers, Hongqing Zhao, Elise Kayson, Constance Orme, Ira Shoulson, (unknown)	2003	110

About Elise Kayson

Elise Kayson is a scholar working on Cellular and Molecular Neuroscience, Neurology, Clinical Biochemistry, Psychiatry and Mental health and Molecular Biology, having authored 22 papers that have together received 1.4k indexed citations. Recurring topics across this work include Genetic Neurodegenerative Diseases (21 papers), Neurological disorders and treatments (11 papers), Mitochondrial Function and Pathology (6 papers), DNA Repair Mechanisms (3 papers), Parkinson's Disease Mechanisms and Treatments (3 papers), BRCA gene mutations in cancer (2 papers), Botulinum Toxin and Related Neurological Disorders (2 papers) and Alcoholism and Thiamine Deficiency (1 paper). The work is most often cited by research in Cellular and Molecular Neuroscience (1.3k citations), Neurology (972 citations), Neurology (94 citations), Molecular Biology (640 citations) and Psychiatry and Mental health (131 citations). Elise Kayson has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Ira Shoulson, Jane S. Paulsen, David Oakes, Martha Nance, Mark Guttman, Douglas R. Langbehn, Michael R. Hayden, Elizabeth Aylward, Leigh J. Beglinger and Karen Duff. Their work appears in journals such as Neurology, Neurotherapeutics, Journal of Huntington s Disease, CNS Spectrums and Movement Disorders.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact